Log In
Print
BCIQ
Print
Print this Print this
 

Actair, House dust mites sublingual immunotherapy tablet (S-524101)

  Manage Alerts
Collapse Summary General Information
Company Stallergenes S.A.
DescriptionSublingual desensitization tablet to house dust mite allergies
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat house dust mite allergic rhinitis
Regulatory Designation

Partner

Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today